Patents by Inventor Lee A. Bulla

Lee A. Bulla has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9566292
    Abstract: This document relates to compositions and methods for modulating an immune response. For example, compositions of immunostimulatory CpG oligonucleotides derived from retroviral genomes are provided.
    Type: Grant
    Filed: June 8, 2015
    Date of Patent: February 14, 2017
    Assignee: Creation One Formulators, LLC
    Inventors: Lee A. Bulla, Jr., Jeffrey Marcus Clark, Natalya Griko, Jian Sun
  • Publication number: 20150342980
    Abstract: This document relates to compositions and methods for modulating an immune response. For example, compositions of immunostimulatory CpG oligonucleotides derived from retroviral genomes are provided.
    Type: Application
    Filed: June 8, 2015
    Publication date: December 3, 2015
    Applicant: CREATION ONE FORMULATORS, LLC
    Inventors: Lee A. BULLA, JR., Natalya Griko, Jian Sun
  • Patent number: 9051360
    Abstract: This document relates to compositions and methods for modulating an immune response. For example, compositions of immunostimulatory CpG oligonucleotides derived from retroviral genomes are provided.
    Type: Grant
    Filed: July 9, 2012
    Date of Patent: June 9, 2015
    Assignee: Creation One Formulators, LLC
    Inventors: Lee A. Bulla, Jr., Natalya Griko, Jian Sun, Ralph Clark
  • Publication number: 20130004538
    Abstract: This document relates to compositions and methods for modulating an immune response. For example, compositions of immunostimulatory CpG oligonucleotides derived from retroviral genomes are provided.
    Type: Application
    Filed: July 9, 2012
    Publication date: January 3, 2013
    Inventors: Lee A. Bulla, JR., Jeffrey Marcus Clark, Natalya Griko, Jian Sun, Ralph Clark
  • Patent number: 8241844
    Abstract: This document relates to compositions and methods for modulating an immune response. For example, compositions of immunostimulatory CpG oligonucleotides derived from retroviral genomes are provided.
    Type: Grant
    Filed: October 2, 2009
    Date of Patent: August 14, 2012
    Inventors: Lee A. Bulla, Jr., Jeffrey Marcus Clark, Ralph Clark, legal representative, Natalya Griko, Jian Sun
  • Publication number: 20100119556
    Abstract: This document relates to compositions and methods for modulating an immune response. For example, compositions of immunostimulatory CpG oligonucleotides derived from retroviral genomes are provided.
    Type: Application
    Filed: October 2, 2009
    Publication date: May 13, 2010
    Inventors: Lee A. Bulla, Jr., Jeffrey Marcus Clark, Ralph Clark, Natalya Griko, Jian Sun
  • Publication number: 20100006438
    Abstract: An efficient system for desalinization of water is described wherein multiple stages of deionization result in drinking water quality and provision is made for recycling wastewater through the system.
    Type: Application
    Filed: July 10, 2009
    Publication date: January 14, 2010
    Applicant: Biological Targets, Inc.
    Inventors: Peter P. ANTICH, Lee A. BULLA, JR.
  • Patent number: 7625743
    Abstract: The cDNA that encodes a glycoprotein receptor from the tobacco hornworm which binds a Bacillus thuringiensis toxin has been obtained and sequenced. The availability of this cDNA permits the retrieval of DNAs encoding homologous receptors in other insects and organisms as well as the design of assays for the cytotoxicity and binding affinity of potential pesticides and the development of methods to manipulate natural and/or introduced homologous receptors and, thus, to destroy target cells, tissues and/or organisms.
    Type: Grant
    Filed: December 19, 2005
    Date of Patent: December 1, 2009
    Assignee: The University of Wyoming
    Inventor: Lee A. Bulla, Jr.
  • Publication number: 20090203049
    Abstract: Recombinant materials for the production of ? integrin protein characteristic of Manduca sexta are useful for screening pesticides for this moth.
    Type: Application
    Filed: January 20, 2009
    Publication date: August 13, 2009
    Inventors: Lee A. BULLA, Mehmet Candas
  • Publication number: 20090198479
    Abstract: A web-based computational system and method for high-throughput gene mining and target identification and validation based on conserved functional blocks automates the generation of conserved regions of high sequence similarity using algorithms and optimizes probe design for fragment amplification from homologous genomes.
    Type: Application
    Filed: July 25, 2008
    Publication date: August 6, 2009
    Inventors: Lee A. BULLA, JR., Jian Sun
  • Publication number: 20090196864
    Abstract: The insecticides of the invention target the downstream portions of the signaling sequence of B. thuringiensis toxin, specifically protein kinase A (PKA) or adenylate cyclase (AC).
    Type: Application
    Filed: October 20, 2006
    Publication date: August 6, 2009
    Inventor: Lee A. Bulla
  • Publication number: 20090098051
    Abstract: A new Bt Cry toxin, Cry1M is able to exert insecticidal effects on insects and/or nematodes in general, and in addition, on insects that have acquired resistance to alternative Cry proteins.
    Type: Application
    Filed: July 11, 2008
    Publication date: April 16, 2009
    Inventors: Mohamed A. IBRAHIM, Lee A. BULLA, JR.
  • Patent number: 7349811
    Abstract: The present invention provides a system, method and apparatus for targeting gene sequences having one or more phenotypic characteristics using a computer. One or more phenotypic characteristics are selected. A gene sequence is then selected that is known to have the selected phenotypic characteristics. In addition, one or more databases containing cataloged gene sequences are selected. The selected gene sequence is compared to the cataloged gene sequences, and any cataloged gene sequences that contain a portion of the selected gene sequence are extracted. The selected gene sequence is aligned to each portion of the extracted gene sequence and the extracted gene sequences are prioritized based on the alignment of the selected gene sequence. At least one of the prioritized gene sequences is selected based on one or more phenotypic criteria. Finally, one or more degenerate primers are designed to target the selected-prioritized gene sequences.
    Type: Grant
    Filed: April 26, 2005
    Date of Patent: March 25, 2008
    Assignee: Board of Regents, The University of Texas System
    Inventors: Lee A. Bulla, Jr., Mehmet Candas
  • Publication number: 20070219269
    Abstract: A bacterial protein which converts 2-methyl citrate to 2-methyl isocitrate is a previously unknown target for antibacterial agents. The protein of this activity is associated with mucoid bacteria and inhibitors of production or activity of this protein in combination with propionic acid mitigate the virulence of these bacteria.
    Type: Application
    Filed: February 27, 2007
    Publication date: September 20, 2007
    Inventors: Mehmet Candas, Lee Bulla
  • Patent number: 7214792
    Abstract: A novel microorganism producing a nontoxic, non-antigenic exopolysaccharide is taught. The exopolysaccharide has neutral sugars migrating at the same rate as mannose, fucose, fructose and galactose, acidic sugars migrating at the same rate as fucose and amine sugars migrating at the same rate as glucose and fucose, and wherein the ratio of galactose:fucose:glucose:mannose is about 1:2:3:6. The microbe and the exopolysaccharide have uses as a biofilm in geologic applications and have several consumer uses as food and drug polymers and use as a plasma extender.
    Type: Grant
    Filed: October 8, 2003
    Date of Patent: May 8, 2007
    Assignee: The Board of Regents, The University of Texas System
    Inventors: Lee A. Bulla, John P. Turner
  • Patent number: 7183100
    Abstract: A bacterial protein which converts 2-methyl citrate to 2-methyl isocitrate is a previously unknown target for antibacterial agents. The protein of this activity is associated with mucoid bacteria and inhibitors of production or activity of this protein in combination with propionic acid mitigate the virulence of these bacteria.
    Type: Grant
    Filed: May 19, 2003
    Date of Patent: February 27, 2007
    Assignee: Biological Targets, Inc.
    Inventors: Mehmet Candas, Lee A. Bulla
  • Publication number: 20070031855
    Abstract: The cDNA that encodes a glycoprotein receptor from the tobacco hornworm which binds a Bacillus thuringiensis toxin has been obtained and sequenced. The availability of this cDNA permits the retrieval of DNAs encoding homologous receptors in other insects and organisms as well as the design of assays for the cytotoxicity and binding affinity of potential pesticides and the development of methods to manipulate natural and/or introduced homologous receptors and, thus, to destroy target cells, tissues and/or organisms.
    Type: Application
    Filed: December 19, 2005
    Publication date: February 8, 2007
    Inventor: Lee Bulla
  • Patent number: 7094554
    Abstract: A cDNA encoding a 200 kD receptor, BT-R2, from the pink boll worm, Pectinophora gossypiella, that binds specifically to a Bacillus thuringiensis toxin has been cloned, sequenced and characterized. The minimum toxin binding fragment has been identified. The BT-R2 cDNA permits the analysis of receptors in pink boll worm and other insects that affect crop growth and development, as well as, design assays for the cytotoxicity and binding affinity of potential pesticides. The clone and other methods described herein, permit the manipulation of natural and/or introduced homologous receptors and, thus, to specifically destroy organisms, tissues and/or cells of the target host.
    Type: Grant
    Filed: July 18, 2003
    Date of Patent: August 22, 2006
    Assignee: The Board of Regents, The University of Texas System
    Inventors: Lee A. Bulla, Mehmet Candas
  • Publication number: 20050266524
    Abstract: Recombinant materials for the production of ? integrin protein characteristic of Manduca sexta are useful for screening pesticides for this moth.
    Type: Application
    Filed: November 29, 2004
    Publication date: December 1, 2005
    Inventors: Lee Bulla, Mehmet Candas
  • Publication number: 20050196807
    Abstract: The present invention provides a system, method and apparatus for targeting gene sequences having one or more phenotypic characteristics using a computer. One or more phenotypic characteristics are selected. A gene sequence is then selected that is known to have the selected phenotypic characteristics. In addition, one or more databases containing cataloged gene sequences are selected. The selected gene sequence is compared to the cataloged gene sequences, and any cataloged gene sequences that contain a portion of the selected gene sequence are extracted. The selected gene sequence is aligned to each portion of the extracted gene sequence and the extracted gene sequences are prioritized based on the alignment of the selected gene sequence. At least one of the prioritized gene sequences is selected based on one or more phenotypic criteria. Finally, one or more degenerate primers are designed to target the selected-prioritized gene sequences.
    Type: Application
    Filed: April 26, 2005
    Publication date: September 8, 2005
    Inventors: Lee Bulla, Mehmet Candas